Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 1
2022 3
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Current Approaches for Personalized Therapy of Soft Tissue Sarcomas.
Kirsanov KI, Lesovaya EA, Fetisov TI, Bokhyan BY, Belitsky GA, Yakubovskaya MG. Kirsanov KI, et al. Among authors: fetisov ti. Sarcoma. 2020 Mar 31;2020:6716742. doi: 10.1155/2020/6716742. eCollection 2020. Sarcoma. 2020. PMID: 32317857 Free PMC article. Review.
Effects of G-Quadruplex-Binding Plant Secondary Metabolites on c-MYC Expression.
Zenkov RG, Kirsanov KI, Ogloblina AM, Vlasova OA, Naberezhnov DS, Karpechenko NY, Fetisov TI, Lesovaya EA, Belitsky GA, Dolinnaya NG, Yakubovskaya MG. Zenkov RG, et al. Among authors: fetisov ti. Int J Mol Sci. 2022 Aug 16;23(16):9209. doi: 10.3390/ijms23169209. Int J Mol Sci. 2022. PMID: 36012470 Free PMC article.
Perspectives of Cell Sensitivity/Resistance Assay in Soft Tissue Sarcomas Chemotherapy.
Fetisov TI, Khazanova SA, Shtompel PA, Trapeznikova ES, Zinovieva VY, Marshall VI, Lovenger AA, Rogozhin DV, Anastasia TA, Bokhyan BY, Belitsky GA, Yakubovskaya MG, Kirsanov KI. Fetisov TI, et al. Int J Mol Sci. 2023 Jul 31;24(15):12292. doi: 10.3390/ijms241512292. Int J Mol Sci. 2023. PMID: 37569668 Free PMC article.
Targeting Features of Curaxin CBL0137 on Hematological Malignancies In Vitro and In Vivo.
Fetisov TI, Borunova AA, Antipova AS, Antoshina EE, Trukhanova LS, Gorkova TG, Zuevskaya SN, Maslov A, Gurova K, Gudkov A, Lesovaya EA, Belitsky GA, Yakubovskaya MG, Kirsanov KI. Fetisov TI, et al. Biomedicines. 2023 Jan 16;11(1):230. doi: 10.3390/biomedicines11010230. Biomedicines. 2023. PMID: 36672738 Free PMC article.
Soft Tissue Sarcoma Study: Association of Genetic Alterations in the Apoptosis Pathways with Chemoresistance to Doxorubicin.
Kirilin EM, Fetisov TI, Moiseeva NI, Lesovaya EA, Laletina LA, Makhmudova LF, Manikaylo AE, Fomina LY, Burov DA, Bokhyan BY, Zinovieva VY, Vilkova AS, Mekheda LV, Kozlov NA, Scherbakov AM, Belitsky GA, Švedas V, Kirsanov KI, Yakubovskaya MG. Kirilin EM, et al. Among authors: fetisov ti. Cancers (Basel). 2022 Apr 1;14(7):1796. doi: 10.3390/cancers14071796. Cancers (Basel). 2022. PMID: 35406568 Free PMC article.
Analysis of Multiple Drug Resistance Mechanism in Different Types of Soft Tissue Sarcomas: Assessment of the Expression of ABC-Transporters, MVP, YB-1, and Analysis of Their Correlation with Chemosensitivity of Cancer Cells.
Moiseeva NI, Laletina LA, Fetisov TI, Makhmudova LF, Manikaylo AE, Fomina LY, Burov DA, Lesovaya EA, Bokhyan BY, Zinovieva VY, Vilkova AS, Mekheda LV, Kozlov NA, Scherbakov AM, Kirilin EM, Belitsky GA, Yakubovskaya MG, Kirsanov KI. Moiseeva NI, et al. Among authors: fetisov ti. Int J Mol Sci. 2022 Mar 16;23(6):3183. doi: 10.3390/ijms23063183. Int J Mol Sci. 2022. PMID: 35328603 Free PMC article.
Irreversible inhibition of estrogen receptor α signaling and the emergence of hormonal resistance in MCF7 breast cancer cells induced by DNA damage agents.
Scherbakov AM, Sorokin DV, Razuvaeva VE, Shchegolev YY, Andreeva OE, Salnikova DI, Fetisov TI, Vlasova OA, Kirsanov KI, Gudkova MV, Krasil'nikov MA. Scherbakov AM, et al. Among authors: fetisov ti. Biomed Rep. 2024 Jan 19;20(3):42. doi: 10.3892/br.2024.1727. eCollection 2024 Mar. Biomed Rep. 2024. PMID: 38343657 Free PMC article.